HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neurokinin B acts via the neurokinin-3 receptor in the retrochiasmatic area to stimulate luteinizing hormone secretion in sheep.

Abstract
Recent data have demonstrated that mutations in the receptor for neurokinin B (NKB), the NK-3 receptor (NK3R), produce hypogonadotropic hypogonadism in humans. These data, together with reports that NKB expression increases after ovariectomy and in postmenopausal women, have led to the hypothesis that this tachykinin is an important stimulator of GnRH secretion. However, the NK3R agonist, senktide, inhibited LH secretion in rats and mice. In this study, we report that senktide stimulates LH secretion in ewes. A dramatic increase in LH concentrations to levels close to those observed during the preovulatory LH surge was observed after injection of 1 nmol senktide into the third ventricle during the follicular, but not in the luteal, phase. Similar increases in LH secretion occurred after insertion of microimplants containing this agonist into the retrochiasmatic area (RCh) in anestrous or follicular phase ewes. A low-dose microinjection (3 pmol) of senktide into the RCh produced a smaller but significant increase in LH concentrations in anestrous ewes. Moreover, NK3R immunoreactivity was clearly evident in the RCh, although it was not found in A15 dopaminergic cell bodies in this region. These data provide evidence that NKB stimulates LH (and presumably GnRH) secretion in ewes and point to the RCh as one important site of action. Based on these data, and the effects of NK3R mutations in humans, we hypothesize that NKB plays an important stimulatory role in the control of GnRH and LH secretion in nonrodent species.
AuthorsHeather J Billings, John M Connors, Stephanie N Altman, Stanley M Hileman, Ida Holaskova, Michael N Lehman, Christina J McManus, Casey C Nestor, Britni H Jacobs, Robert L Goodman
JournalEndocrinology (Endocrinology) Vol. 151 Issue 8 Pg. 3836-46 (Aug 2010) ISSN: 1945-7170 [Electronic] United States
PMID20519368 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Neurotransmitter Agents
  • Peptide Fragments
  • Receptors, Neurokinin-3
  • senktide
  • Substance P
  • Gonadotropin-Releasing Hormone
  • Neurokinin B
  • Luteinizing Hormone
  • Dopamine
Topics
  • Anestrus (blood, drug effects)
  • Animals
  • Brain (drug effects, metabolism)
  • Dopamine (metabolism)
  • Female
  • Follicular Phase (drug effects, metabolism, physiology)
  • Gonadotropin-Releasing Hormone (blood, metabolism)
  • Injections, Intraventricular
  • Luteal Phase (drug effects, metabolism, physiology)
  • Luteinizing Hormone (blood, metabolism)
  • Models, Biological
  • Neurokinin B (pharmacology, physiology)
  • Neurons (drug effects, metabolism)
  • Neurotransmitter Agents (pharmacology)
  • Peptide Fragments (administration & dosage, pharmacology)
  • Receptors, Neurokinin-3 (agonists, metabolism, physiology)
  • Sheep
  • Substance P (administration & dosage, analogs & derivatives, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: